Heparin
Heparin is a pharmaceutical drug with 140 clinical trials. Currently 11 active trials ongoing. Historical success rate of 84.0%.
Success Metrics
Based on 68 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
21
Mid Stage
63
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
72.3%
68 of 94 finished
27.7%
26 ended early
11
trials recruiting
140
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
Reprometabolic Syndrome Mediates Subfertility in Obesity
Heparin vs Placebo for Cardiac Catheterization
Clinical Trials (140)
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
Reprometabolic Syndrome Mediates Subfertility in Obesity
Heparin vs Placebo for Cardiac Catheterization
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
Reduced Anticoagulation Targets in ECLS (RATE)
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation
Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 140